FilingSEC EDGARS-8
Nasus Pharma Registers Additional 200,000 Shares for Incentive Option Plan
· SEC accepted
StageRegistered
Filing content
Nasus Pharma registered 200,000 additional ordinary shares to be reserved for issuance under its 2019 Incentive Option Plan for U.S. persons.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…